Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 2Phase 3 1

Status

Completed 29Recruiting 5Unknown 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5

Conditions

Sarcoma 2Leiomyosarcoma Uterus 1Leiomyosarcoma 1Chondrosarcoma, Mesenchymal 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Trabectedin × Clear all
NCT04305548 2026-03-27

ISG-MCS

Italian Sarcoma Group

Phase 2 Recruiting
16 enrolled
Sarcoma

Chondrosarcoma, Mesenchymal

NCT04383119 2026-03-25

ISG-ARTICLE

Italian Sarcoma Group

Phase 2 Recruiting
100 enrolled
Sarcoma

Sarcoma

NCT06524583 2025-03-30

L-UteCIN

UNICANCER

Phase 2 Recruiting
198 enrolled
Sarcoma

Leiomyosarcoma Uterus

NCT03886311 2025-02-24

TNT

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
200 enrolled
Sarcoma

Sarcoma

NCT04535271 2025-02-24

TAGGED

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
80 enrolled
Sarcoma

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡